Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
American Journal of Physiology. Cell Physiology|September 16, 2020
Thrombospondins in bone remodeling and metastatic bone diseaseLaura Carminati, Giulia TarabolettiCancers|April 30, 2021
Alternative Vascularization Mechanisms in Tumor Resistance to TherapyDorina Belotti, Denise Pinessi, Giulia TarabolettiCancer Metastasis Reviews|September 27, 2007
Tumor-host interaction in the optimization of paclitaxel-based combination therapies with vascular targeting compoundsRaffaella Giavazzi, Maria Rosa Bani, Giulia TarabolettiMatrix Biology : Journal of the International Society for Matrix Biology|April 1, 2023
Controlled extracellular proteolysis of thrombospondinsLaura Carminati, Elena Carlessi, Elisa Longhi, et al.Matrix Biology : Journal of the International Society for Matrix Biology|January 31, 2014
Current understanding of the thrombospondin-1 interactomeAndrea Resovi, Denise Pinessi, Giovanna Chiorino, et al.Anti-Cancer Drugs|April 8, 2003
IDN 5390: a new concept in taxane developmentGiulia Taraboletti, Gianluca Micheletti, Raffaella Giavazzi, et al.Oncotarget|February 15, 2011
Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitorsGiulia Taraboletti, Marco Rusnati, Laura Ragona, et al.Life Sciences|March 31, 2004
ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endotheliumSandra Donnini, Lucia Morbidelli, Giulia Taraboletti, et al.International Journal of Molecular Sciences|September 23, 2022
Inhibition of FGFR Signaling by Targeting FGF/FGFR Extracellular Interactions: Towards the Comprehension of the Molecular Mechanism through NMR ApproachesKatiuscia Pagano, Elisa Longhi, Henriette Molinari, et al.The International Journal of Biochemistry & Cell Biology|August 26, 2011
Targeting angiogenesis with compounds from the extracellular matrixDorina Belotti, Chiara Foglieni, Andrea Resovi, et al.Pageof 6